PhillyPharma Archive: April, 2013

GlaxoSmithKline and Humana, drug companies and insurers awaiting Supreme Court decision

Comment icon 0 Comments
The U.S. Supreme Court justices are scheduled to have one of their regular conferences to consider what cases they will decide to hear in full... Read more

FDA schedules June meeting to re-examine Avandia clinical trial results

Comment icon 0 Comments
The U.S. Food and Drug Administration posted a notice on the federal register that it will hold a joint meeting of two advisory committees... Read more

Pfizer spent big money on lobbying when new PA health department secretary worked there

Comment icon 0 Comments
Michael Wolf was named secretary of the Pennsylvania health department by Gov. Corbett on Monday, as Inquirer colleague Amy Worden wrote the... Read more

Glaxo's Andrew Witty on CEO choices, financial guidance, smaller facilities and hiring people with heart

Comment icon 0 Comments
GlaxoSmithKline chief executive officer Andrew Witty said in an interview with The Inquirer that leaders must decide whether to use their positions... Read more

Why do Medicare, Medicaid and Veterans Affairs deal with drug costs differently?

Comment icon 0 Comments
Countries sometimes do things differently from other countries or gain reputations for doing certain things well or poorly. But within a country... Read more

Merck CEO Ken Frazier says West Point facility near Philly is safe for now

Comment icon 0 Comments
Princeton, N.J. - Merck & Co., chief executive officer Ken Frazier told The Inquirer that the drugmaker's facility in the Philadelphia... Read more

Inquirer architecture critic Inga Saffron reviews GlaxoSmithKline's new building at the Philadelphia Navy Yard

Comment icon 0 Comments
The Inquirer's architecture critic, Inga Saffron, toured and reviewed GlaxoSmithKline's new building at the Philadelphia Navy Yard. A link... Read more

Healthcare and pharmaceutical job cuts continue, according to Challenger, Gray & Christmas

Comment icon 0 Comments
Healthcare and pharmaceutical companies continued to shed jobs in March and the rest of the first quarter of 2013, according to the latest... Read more